Company: ICUI
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000883984-25-000016
Chunk: 32

Company: ICU MEDICAL INC/DE
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 32
---
 none— — Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 24,611 shares at March 31, 2025 and 24,518 shares at December 31, 2024; and outstanding — 24,611 shares at March 31, 2025 and 24,517 shares at December 31, 20242,461 2,452 Additional paid-in capital1,416,001 1,412,118 Treasury stock, at cost (420 shares at March 31, 2025 and 571 shares at December 31, 2024)(60)(92)Retained earnings674,682 690,158 Accumulated other comprehensive loss(105,395)(139,401)TOTAL STOCKHOLDERS' EQUITY1,987,689 1,965,235 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$4,184,581 $4,203,931 

______________________________________________________

(1) December 31, 2024 balances were derived from audited consolidated financial statements.

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Table of Contents

ICU MEDICAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In thousands, except per share data)

 Three months ended March 31, 20252024TOTAL REVENUES$604,702 $566,655 COST OF GOODS SOLD394,593 381,411 GROSS PROFIT210,109 185,244 OPERATING EXPENSES:  Selling, general and administrative157,233 157,657 Research and development23,291 21,842 Restructuring, strategic transaction and integration16,697 16,105 Change in fair value of contingent earn-out— 295 TOTAL OPERATING EXPENSES197,221 195,899 INCOME (LOSS) FROM OPERATIONS12,888 (10,655)INTEREST EXPENSE, NET(22,031)(23,772)OTHER EXPENSE, NET(1,763)(2,341)LOSS BEFORE INCOME TAXES(10,906)(36,768)PROVISION FOR INCOME TAXES(4,570)(2,703)NET LOSS$(15,476)$(39,